215 related articles for article (PubMed ID: 31981888)
21. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
[TBL] [Abstract][Full Text] [Related]
22. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Turjanski N; Bhatia K; Burn DJ; Sawle GV; Marsden CD; Brooks DJ
Neurology; 1993 Aug; 43(8):1563-8. PubMed ID: 8351012
[TBL] [Abstract][Full Text] [Related]
23. 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
Hoshi H; Kuwabara H; Léger G; Cumming P; Guttman M; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):57-69. PubMed ID: 8417011
[TBL] [Abstract][Full Text] [Related]
24. Rate of 6-[18F]fluorodopa uptake decline in striatal subregions in Parkinson's disease.
Gallagher CL; Oakes TR; Johnson SC; Chung MK; Holden JE; Bendlin BB; McLaren DG; Xu G; Nickles RJ; Pyzalski R; DeJesus O; Brown WD
Mov Disord; 2011 Mar; 26(4):614-20. PubMed ID: 21449008
[TBL] [Abstract][Full Text] [Related]
25. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
26. Comparative Performance of 99mTc-TRODAT-1 SPECT/CT and 18F-FDOPA PET/CT Imaging in Patients With Parkinson's Disease, Parkinson-Plus Syndrome, and Essential Tremor.
Sood A; Shukla J; Shree R; Vatsa R; Modi M; Mittal BR
Clin Nucl Med; 2021 Feb; 46(2):95-102. PubMed ID: 33234920
[TBL] [Abstract][Full Text] [Related]
27. A longitudinal study of motor performance and striatal [18F]fluorodopa uptake in Parkinson's disease.
Gallagher CL; Johnson SC; Bendlin BB; Chung MK; Holden JE; Oakes TR; Brooks BR; Konopacki RA; Dogan S; Abbs JH; Xu G; Nickles RJ; Pyzalski RW; Dejesus OT; Brown WD
Brain Imaging Behav; 2011 Sep; 5(3):203-11. PubMed ID: 21556744
[TBL] [Abstract][Full Text] [Related]
28. Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels.
Criswell SR; Perlmutter JS; Crippin JS; Videen TO; Moerlein SM; Flores HP; Birke AM; Racette BA
Arch Neurol; 2012 Mar; 69(3):394-7. PubMed ID: 22410448
[TBL] [Abstract][Full Text] [Related]
29. Salivary Gland Uptake on
Kang SY; Yun JY; Kang YK; Moon BS; Yoon HJ; Yoo MY; Kim BS
Korean J Radiol; 2023 Jul; 24(7):690-697. PubMed ID: 37404111
[TBL] [Abstract][Full Text] [Related]
30. Comparison of [18F]FDOPA, [18F]FMT and [18F]FECNT for imaging dopaminergic neurotransmission in mice.
Honer M; Hengerer B; Blagoev M; Hintermann S; Waldmeier P; Schubiger PA; Ametamey SM
Nucl Med Biol; 2006 Jul; 33(5):607-14. PubMed ID: 16843835
[TBL] [Abstract][Full Text] [Related]
31. Contralateral Posterior Putaminal
Zhou LL; Wang SY; Tian YY; Jiang T; Chen YC; Huang T; Zhang YD; Wang F
Curr Neurovasc Res; 2021; 18(4):465-469. PubMed ID: 34809545
[TBL] [Abstract][Full Text] [Related]
32. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
Sawle GV; Playford ED; Burn DJ; Cunningham VJ; Brooks DJ
Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
[TBL] [Abstract][Full Text] [Related]
33. Onset-related subtypes of Parkinson's disease differ in the patterns of striatal dopaminergic dysfunction: A positron emission tomography study.
Liu SY; Wu JJ; Zhao J; Huang SF; Wang YX; Ge JJ; Wu P; Zuo CT; Ding ZT; Wang J
Parkinsonism Relat Disord; 2015 Dec; 21(12):1448-53. PubMed ID: 26559130
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDOPA PET for the diagnosis of parkinsonian syndromes.
Darcourt J; Schiazza A; Sapin N; Dufour M; Ouvrier MJ; Benisvy D; Fontana X; Koulibaly PM
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):355-65. PubMed ID: 25366711
[TBL] [Abstract][Full Text] [Related]
35. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease.
Kaasinen V; Maguire RP; Hundemer HP; Leenders KL
J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426
[TBL] [Abstract][Full Text] [Related]
36. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
[TBL] [Abstract][Full Text] [Related]
37. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Morrish PK; Rakshi JS; Bailey DL; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):314-9. PubMed ID: 9527140
[TBL] [Abstract][Full Text] [Related]
38. Onset pattern of nigrostriatal denervation in early Parkinson's disease.
Pineda-Pardo JA; Sánchez-Ferro Á; Monje MHG; Pavese N; Obeso JA
Brain; 2022 Apr; 145(3):1018-1028. PubMed ID: 35349639
[TBL] [Abstract][Full Text] [Related]
39. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
[TBL] [Abstract][Full Text] [Related]
40. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.
Antonini A; Kazumata K; Feigin A; Mandel F; Dhawan V; Margouleff C; Eidelberg D
Mov Disord; 1998 Mar; 13(2):268-74. PubMed ID: 9539340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
